18650 Cells safety test

Standardization and Testing. Potency is determiaed by quantitating the Hepatitis B antigen by an antibody-biading assay combiaed with a determination of the amount of proteia. Safety testing typical for cell culture-derived products is also performed, and iacludes assuting the absence of Hve vims. 

Standardization and Testing. Potency is determined by titrating the amount of Hve vims using a suitable cell substrate. Safety testing is also performed on seed lots to assure proper attenuation and on vaccine to assure absence of unwanted contaminants. 

V2O5-P205 (95 5, molar ratio) cathode and a lithium anode (Li/a-V205 cell) [1]. In this section, we describe safety test results for AA Li/a- V2Os cells. The AA cell we fabricated has a pressure vent, a Polyswitch (PS, Raychem Co., thermal and current fuse) and is composed of a spirally wound cathode sheet, a metallic Li-based anode sheet and a polyethylene (PE) separator [87]. 

The basic considerations regarding the cell safety and the test results are described briefly below. 

Underwriters Laboratories (UL) requires that consumer batteries pass a number of safety tests [3]. UL requires that a battery withstand a short circuit without fire or explosion. A positive temperature coefficient (PTC) device [4] is used for external short-circuit protection. The resistance of a PTC placed in series with the cell increases by orders of magnitude at high currents and resulting high temperatures. However, in the case of an internal short, e.g., if the positive tab comes lose and contacts the interior of the negative metal can, the separator could act as a fuse. That is, the impedance of the separator increases by two to three orders of magnitude due to an increase in cell temperature. 

Underwriters Laboratories Inc. (UL) UL is an independent, not-for-profit product safety testing and certification organization. UL has tested products for public safety for more than a century with more than 14 billion UL Marks applied to products worldwide. UL has developed a standard for inverters that can be applied to fuel cells. 

SVO material utilized was prepared via a combination reaction. A spirally wound lithium/SVO cell was also described in 1998 by Takeuchi et al. [63], This cell achieved a volumetric energy density of 540 Wh/1, delivered greater than 50% of theoretical capacity under loads greater than 3 j, and was successfully pulse discharged at 2.0 A. Several safety tests were conducted, including short-circuit, forced overdischarge, crush, and charging tests, and the cells did not rupture, vent, or leak under these abusive conditions. 

The U.S. standard pertussis vaccine is used to standardize the potency of the whole cell pertussis vaccine. The number of protective units in the vaccine is estimated for each lot from the results of simultaneous intracerebral mouse-protection tests of the vaccine being studied and the U.S. reference standard (14,17). The potency of the acellular vaccines is estimated by their ability to produce antibodies to the proteins in the vaccine in a mouse model. These vaccines also undergo a series of animal safety tests to ensure that the inactivation and toxoiding steps were carried out correcdy (14,17). 

The value of cultured stem cells to toxicology is in their promise as a continuous source of cells that can be induced to express a chosen cell-type-specific mature phenotype. This achievement would address two current limitations in safety testing scarcity of metabolically competent human systems and use of experimental animals. Numerous culture additives and conditions have been identified that cause commitment and partial differentiation along specific lineages, such as retinoic-acid-induced neuronal commitment of mouse embryonic stem cells. However, definition of conditions that produce fully differentiated cells with cell-type-specific function quantitatively similar to that of intact tissue remains problematic and is a high-priority research area in toxicology. 

Have a relatively long life span. The cells should produce sufficient progeny so they can be tissue banked, characterized, engineered, safety tested, and clinical lot manufactured. 

The characterization and safety testing of the cell banks has been described extensively elsewhere [16]. In brief, the identity, sterility, viral safety, absence of PrPsc protein, tumorigenicity and genetic characterization, including chromosome analysis, has been performed. 

Develop upstream and downstream processes and determine formulation concurrent with safety testing of the cell bank. 

---